Status:
UNKNOWN
Nutritional Study to Determine the Effect of Fish Oil on Atopic Dermatitis
Lead Sponsor:
Møreforsking AS
Collaborating Sponsors:
Helse Møre og Romsdal HF
Epax Norway AS
Conditions:
Atopic Dermatitis
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Atopic Dermatitis is associated with pronounced changes in the lipid composition in the skin. The lipid changes are influenced by and contributing to both the inflammatory circuit and the impaired bar...
Detailed Description
Women and men will be recruited to a placebo or a cetoleic-rich fish oil group and be examined for the effect on atopic dermatitis before, during and after the study period.
Eligibility Criteria
Inclusion
- Women and men 18-80 years of age.
- Diagnosed with active mild to moderate atopic dermatitis with an EASI of 1.1- 21.0.
- Willing to refrain from oil supplements (omega-3, borage, evening primrose, etc.) for 1 month before study begin (washout) and during the study
- Willing to take the study supplement for 6 months
Exclusion
- Known allergy to fish products
- Subjects known to be pregnant or breast feeding
- Subjects perceiving systemically administered medication for AD (other than topical)
- Subjects with auto-immune diseases (except asthma and seasonal/perennial rhinitis)
- Subjects with a diagnosis of other skin diseases
Key Trial Info
Start Date :
December 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 10 2024
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06194045
Start Date
December 1 2023
End Date
October 10 2024
Last Update
January 12 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Helse Møre og Romsdal HF
Ålesund, Møre og Romsdal, Norway, 6017